Literature DB >> 15854959

Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection.

Andrew D Shaw1, Ara A Vaporciyan, Xifeng Wu, Terri M King, Margaret R Spitz, Joe B Putnam, Burton F Dickey.   

Abstract

BACKGROUND: Polymorphisms in genes encoding proteins involved in the inflammatory response may lead to a differential response to a noxious stimulus. We hypothesized that proinflammatory alleles at candidate loci would predispose patients undergoing lung resection to cardiopulmonary complications with a presumed inflammatory cause.
METHODS: We determined the genotypes at six candidate loci in 155 patients who underwent 160 lung resection operations at our center. We correlated these results with data from our clinical database, constructed a model predicting the risk of postoperative complications, and assessed its adequacy using receiver operating characteristic curve methodology.
RESULTS: Preexisting cardiovascular disease (p < 0.001), primary lung cancer (p = 0.009), extent of lung resection (p = 0.042), interleukin 6 genotype (p = 0.017), and tumor necrosis factor genotype (p = 0.005) were significantly associated with complications. The odds ratio for complications for rare allele homozygosity was 3.9 (95% confidence interval, 1.4 to 10.4) for interleukin 6 and 15.3 (95% confidence interval, 1.7 to 131.4) for tumor necrosis factor. In multivariate analysis we found that cardiovascular disease (p < 0.001; odds ratio, 4.0 [95% confidence interval, 1.9 to 8.6]), interleukin 6 genotype (p = 0.027; odds ratio, 1.8 [95% confidence interval, 1.1 to 3.1]), and tumor necrosis factor genotype (p = 0.011; odds ratio, 2.5 [95% confidence interval, 1.2 to 5.1]) were independently predictive of complications, with an area under the receiver operating characteristic curve for the entire model of 0.765.
CONCLUSIONS: Carriage of specific alleles, and homozygosity in particular, at loci within the interleukin 6 and tumor necrosis factor genes appears to contribute to the risk of experiencing an adverse event after lung resection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15854959     DOI: 10.1016/j.athoracsur.2004.10.010

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

Review 1.  Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Authors:  Debra A Schwinn; Mihai Podgoreanu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-03

2.  Usefulness of combining clinical and biochemical parameters for prediction of postoperative pulmonary complications after lung resection surgery.

Authors:  Ignacio Garutti; Francisco De la Gala; Patricia Piñeiro; Lisa Rancan; Elena Vara; Almudena Reyes; Luis Puente-Maestu; Jose María Bellón; Carlos Simón
Journal:  J Clin Monit Comput       Date:  2019-01-17       Impact factor: 2.502

3.  A randomized, double blind, placebo controlled clinical trial of the preoperative use of ketamine for reducing inflammation and pain after thoracic surgery.

Authors:  Richard C D'Alonzo; Elliott Bennett-Guerrero; Mihai Podgoreanu; Thomas A D'Amico; David H Harpole; Andrew D Shaw
Journal:  J Anesth       Date:  2011-08-02       Impact factor: 2.078

4.  Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.

Authors:  Nicholas T Woods; Alvaro N Monteiro; Zachary J Thompson; Ernest K Amankwah; Nina Naas; Eric B Haura; Amer A Beg; Matthew B Schabath
Journal:  Mol Carcinog       Date:  2015-01-18       Impact factor: 4.784

5.  Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer.

Authors:  C Bodelon; M Y Polley; T J Kemp; A C Pesatori; L M McShane; N E Caporaso; A Hildesheim; L A Pinto; M T Landi
Journal:  Ann Oncol       Date:  2013-05-16       Impact factor: 32.976

6.  Perioperative genomic profiles using structure-specific oligonucleotide probes.

Authors:  Kirk J Hogan; James K Burmester; Michael D Caldwell; Quinn H Hogan; Douglas B Coursin; Dawn N Green; Rebecca M R Selzer; Thomas P Broderick; Deborah A Rusy; Mark Poroli; Anna L Lutz; Allison M Sanders; Mary C Oldenburg; James A Koelbl; Monika de Arruda-Indig; Jennifer L Halsey; Stephen P Day; Michael J Domanico
Journal:  Clin Med Res       Date:  2009-05-27

7.  Variations in the vascular endothelial growth factor pathway predict pulmonary complications.

Authors:  Jae Y Kim; Michelle A T Hildebrandt; Xia Pu; Yuanqing Ye; Arlene M Correa; Ara A Vaporciyan; Xifeng Wu; Jack A Roth
Journal:  Ann Thorac Surg       Date:  2012-07-12       Impact factor: 4.330

8.  Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients.

Authors:  Michelle A T Hildebrandt; Jack A Roth; Ara A Vaporciyan; Xia Pu; Yuanqing Ye; Arlene M Correa; Jae Y Kim; Stephen G Swisher; Xifeng Wu
Journal:  Sci Rep       Date:  2015-07-13       Impact factor: 4.379

9.  Serial characterisation of monocyte and neutrophil function after lung resection.

Authors:  Richard O Jones; Mairi Brittan; Niall H Anderson; Andrew Conway Morris; John T Murchison; William S Walker; A John Simpson
Journal:  BMJ Open Respir Res       Date:  2014-09-16

10.  Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery.

Authors:  Craig P Hersh; Dawn L DeMeo; John J Reilly; Edwin K Silverman
Journal:  Respir Res       Date:  2007-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.